Your browser doesn't support javascript.
loading
A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer.
Schneeweiss, A; Marmé, F; Ruiz, A; Manikhas, A G; Bottini, A; Wolf, M; Sinn, H-P; Mansouri, K; Kennedy, L; Bauknecht, T.
Afiliação
  • Schneeweiss A; Department of Gynecology and Obstetrics, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany. Electronic address: andreas.schneeweiss@med.uni-heidelberg.de.
  • Marmé F; Department of Gynecology and Obstetrics, National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany.
  • Ruiz A; Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain.
  • Manikhas AG; Breast Cancer Department, City Oncology Dispensary, St Petersburg, Russian Federation.
  • Bottini A; Breast Unit, Azienda Ospedaliera Istituti Ospitalieri, Cremona, Italy.
  • Wolf M; Center for Breast Diseases, Vivantes-Klinikum am Urban, Berlin.
  • Sinn HP; Department of Pathology, University of Heidelberg, Heidelberg.
  • Mansouri K; Lilly Deutschland GmbH, Bad Homburg, Germany.
  • Kennedy L; Lilly United Kingdom, Erl Wood Manor, Surrey, UK.
  • Bauknecht T; Lilly Deutschland GmbH, Bad Homburg, Germany.
Ann Oncol ; 22(3): 609-617, 2011 Mar.
Article em En | MEDLINE | ID: mdl-20732932

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Lobular / Carcinoma Ductal de Mama Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Lobular / Carcinoma Ductal de Mama Idioma: En Ano de publicação: 2011 Tipo de documento: Article